Latest Bing Center News
Welcome to the WM Digest: a place where you can find vital information and education about Waldenstrom macroglobulinemia (WM), hear the latest WM research updates, meet WM community members who share their stories, and get diverse support for managing WM.
A forward-looking overview of promising therapies and ongoing clinical trials. This session highlights what may shape the future of WM treatment and care. Dr. Steven Treon is the Director of the Bing Center for Waldenström's Macroglobulinemia Research and an attending physician for medical oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital, in Boston, Massachusetts. He is the Robert F. Tannenhauser Chair for Waldenström’s Research, an Associate Professor of Medicine at Harvard Medical School in Boston, and is the Chair of the Waldenström's Macroglobulinemia Clinical Trials Group.
Your most pressing questions are addressed directly by leading WM experts. During this session, physicians respond in real time, offering practical insights, clinical perspective, and clarity on complex issues across the WM journey. The session features a panel of incredible WM doctors including Stephen Ansell, MD, PhD, Christian Buske, Prof. Dr. Jorge Castillo, MD, Prof Shirley D'Sa, Peter Forsberg, MD, Yazeed Sawalha, MD, and Steven Treon, MD, PhD.
Welcome to the WM Digest: a place where you can find vital information and education about Waldenstrom macroglobulinemia (WM), hear the latest WM research updates, meet WM community members who share their stories, and get diverse support for managing WM.
Welcome to the WM Digest: a place where you can find vital information and education about Waldenstrom macroglobulinemia (WM), hear the latest WM research updates, meet WM community members who share their stories, and get diverse support for managing WM. This issue includes news about IWWM-13, scheduled for October 13-17 in Palm Springs!
The Waldenstrom Digest from the International Waldenstrom Macroglobulinemia Foundation (IWMF) provides a comprehensive update on medical advancements and community support for those affected by this rare blood cancer. This issue highlights the upcoming IWWM-13 conference in Palm Springs, which will feature the first-ever session dedicated to translating complex scientific research into practical patient takeaways.
Welcome to the WM Digest: a place where you can find vital information and education about Waldenstrom macroglobulinemia (WM), hear the latest WM research updates, meet WM community members who share their stories, and get diverse support for managing WM.
Welcome to the WM Digest: a place where you can find vital information and education about Waldenstrom macroglobulinemia (WM), hear the latest WM research updates, meet WM community members who share their stories, and get diverse support for managing WM.
Peter Bing, MD, was a nationally- renowned philanthropist and public health expert. Dr. Bing served as executive director of the National Advisory Commission on Health Manpower during the Johnson Administration and made significant contributions to the Dana-Farber Cancer Institute in Boston (DFCI) to support research on Waldenström’s Macroglobulinemia (WM), a rare and chronic type of slow-growing, non-Hodgkin’s lymphoma.
Founded in 1999, the WM program at DFCI was officially designated as the Bing Center for Waldenström’s Macroglubulinemia in 2005 in honor of Dr. Bing. Led by Dr. Steven Treon, the Bing Center aims to advance understanding of the cause of WM and pursue novel therapies.
Welcome to the WM Weekly: a place where you can find vital information and education about Waldenstrom macroglobulinemia (WM), hear the latest WM research updates, meet WM community members who share their stories, and get diverse support for managing WM.